
According to Reuters, far more executives from technology companies than outspoken tech critics were named to US President-elect Joe Biden’s transition team on Tuesday, November 10, offering clues on who will decide on filling key roles and ultimately influence his administration’s thinking in coming years.
Tech companies have been trying to strengthen their relationship with a future Biden administration to ensure they have a voice in an onslaught of federal and state investigations of their business practices.
The Biden transition team released a list of agency review teams on Tuesday.
Amazon’s Tom Sullivan, an executive on the public policy team, will be part of Biden’s review team overseeing the Department of State. Similarly, Mark Schwartz from Amazon’s cloud computing arm, who is also a former Obama administration official, will be weighing in on decisions for the Office of Management and Budget.
Microsoft-owned LinkedIn’s senior director for North America policy, Nicole Isaac, will be part of the team overseeing the Department of Treasury.
A Biden transition team spokesman said agency review teams are responsible for evaluating the operations of the federal agencies and making sure the Biden-Harris administration can achieve policy goals discussed during the campaign.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas